Literature DB >> 11054087

Haemostatic screening and identification of zebrafish mutants with coagulation pathway defects: an approach to identifying novel haemostatic genes in man.

P Jagadeeswaran1, M Gregory, S Johnson, B Thankavel.   

Abstract

Zebrafish were used as a model to study haemostasis, a vertebrate function of paramount importance. A limitation of the zebrafish model is the difficulty in assaying small amounts of blood to detect coagulation mutants. We report the use of a rapid total coagulation activity (TCA) assay to screen for coagulation defects in individual adult zebrafish. We screened the TCA in 1000 gynogenetic half-tetrad diploids derived from 86 clutches. Each clutch was from a single F1 female offspring of males mutagenized with ethylnitrosourea (ENU). We found 30-50% defective zebrafish among six clutches, consistent with a heritable defect. The assay developed here provided a rapid screen to detect overall coagulation defects. However, because of the limited amounts of plasma, we could not detect defects in specific pathways. Therefore, a novel, ultra-sensitive kinetic method was developed to identify specific pathway defects. To test whether the kinetic assay could be used as a screening tool, 1500 Florida wild-type zebrafish pairs were analysed for naturally occurring coagulation defects. We detected 30 fish with extrinsic pathway defects, but with intact common and intrinsic pathways. We conclude that it is now possible to identify specific coagulation pathway defects in zebrafish.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054087     DOI: 10.1046/j.1365-2141.2000.02284.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

1.  Coupled mutagenesis screens and genetic mapping in zebrafish.

Authors:  John F Rawls; Matthew R Frieda; Anthony R McAdow; Jason P Gross; Chad M Clayton; Candy K Heyen; Stephen L Johnson
Journal:  Genetics       Date:  2003-03       Impact factor: 4.562

Review 2.  Fishing for novel angiogenic therapies.

Authors:  Kameha R Kidd; Brant M Weinstein
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

3.  Knockout of von Willebrand factor in Zebrafish by CRISPR/Cas9 mutagenesis.

Authors:  Neha Iyer; Vanina T Tcheuyap; Sara Schneider; Vanessa Marshall; Pudur Jagadeeswaran
Journal:  Br J Haematol       Date:  2019-04-09       Impact factor: 6.998

Review 4.  Fish to Learn: Insights into Blood Development and Blood Disorders from Zebrafish Hematopoiesis.

Authors:  Serine Avagyan; Leonard I Zon
Journal:  Hum Gene Ther       Date:  2016-04       Impact factor: 5.695

5.  Demonstration of the extrinsic coagulation pathway in teleostei: identification of zebrafish coagulation factor VII.

Authors:  J Sheehan; M Templer; M Gregory; R Hanumanthaiah; D Troyer; T Phan; B Thankavel; P Jagadeeswaran
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

Review 6.  The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations.

Authors:  Jan M Spitsbergen; Michael L Kent
Journal:  Toxicol Pathol       Date:  2003 Jan-Feb       Impact factor: 1.902

7.  Cationic PAMAM dendrimers aggressively initiate blood clot formation.

Authors:  Clinton F Jones; Robert A Campbell; Amanda E Brooks; Shoeleh Assemi; Soheyl Tadjiki; Giridhar Thiagarajan; Cheyanne Mulcock; Andrew S Weyrich; Benjamin D Brooks; Hamidreza Ghandehari; David W Grainger
Journal:  ACS Nano       Date:  2012-10-24       Impact factor: 15.881

Review 8.  Zebrafish in hematology: sushi or science?

Authors:  Duncan Carradice; Graham J Lieschke
Journal:  Blood       Date:  2008-01-08       Impact factor: 22.113

9.  Zebrafish thrombocytes: functions and origins.

Authors:  Gauri Khandekar; Seongcheol Kim; Pudur Jagadeeswaran
Journal:  Adv Hematol       Date:  2012-06-24

10.  Thrombin Generation in Zebrafish Blood.

Authors:  Evelien Schurgers; Martijn Moorlag; Coenraad Hemker; Theo Lindhout; Hilde Kelchtermans; Bas de Laat
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.